Veradigm 

$4.85
24
+$0.05+1.04% Monday 19:43

Statistics

Day High
4.89
Day Low
4.8
52W High
6
52W Low
3
Volume
9,961
Avg. Volume
110,828
Mkt Cap
525.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Oct 8
$5.23
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

7AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.01
0.11
0.21
0.31
Expected EPS
0.09
Actual EPS
N/A

Financials

-14.7%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
1.18BRevenue
-172.92MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDRX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Veradigm Inc. is a global healthcare technology enterprise that delivers cutting-edge information technology platforms to a diverse client base, including healthcare providers, health plans (payers), and biopharmaceutical companies, operating across the United States and various international markets. For healthcare providers, the company offers a suite of integrated solutions designed to optimize operations. These include Practice Management software, AI-driven Patient Scheduling tools, and systems for Electronic Statements and Payments. Veradigm also provides comprehensive revenue cycle management, encompassing specialized services and a dedicated clearinghouse to streamline financial workflows. Furthermore, their electronic health records (EHR) portfolio features advanced options like ePrescribe with EPCS, Veradigm HER, and Practice Fusion HER, complemented by a robust Patient Engagement Platform. The firm extends its offerings to network partners through a variety of connectivity solutions. These comprise API integration tools such as Veradigm Connect and Veradigm App Expo, a Diagnostic Ordering and Resulting Network, a Channel Partner Program, and Veradigm ePrescribe Enterprise. Health plans and payers benefit from Veradigm's specialized solutions, which include sophisticated risk adjustment tools like Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics. They also provide quality management systems, including quality analytics and integrated risk adjustment and quality management features. Data exchange and coding solutions, such as eChart Courier, eChart Coder, and eChart Integration and Analytics, further enhance efficiency. Additionally, Veradigm offers provider engagement platforms like Veradigm Payer Insights and the comprehensive Veradigm Payerpath suite. For the biopharma sector, Veradigm supplies valuable real-world data solutions, including extensive health datasets and specialized registries for cardiology and metabolic conditions. This is coupled with real-world evidence platforms, such as the Real World Evidence Analytics Platform. Therapy-focused data is available for key areas like cardiovascular, central nervous system, metabolic, and immunology. The company also delivers Digital Health Media solutions. Established in 1986 and headquartered in Chicago, Illinois, Veradigm Inc. was previously known as Allscripts Healthcare Solutions, Inc., before rebranding to its current name in January 2023.
Show more...
CEO
Mr. Donald D. Trigg
Employees
2450
Country
United States
ISIN
US01988P1084

Listings

0 Comments

Share your thoughts

FAQ

What is Veradigm stock price today?
The current price of MDRX is $4.85 USD — it has increased by +1.04% in the past 24 hours. Watch Veradigm stock price performance more closely on the chart.
What is Veradigm stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Veradigm stocks are traded under the ticker MDRX.
Is Veradigm stock price growing?
MDRX stock has risen by +1.04% compared to the previous week, the month change is a -3% fall, over the last year Veradigm has showed a +10.23% increase.
What is Veradigm market cap?
Today Veradigm has the market capitalization of 525.09M
When is the next Veradigm earnings date?
Veradigm is going to release the next earnings report on August 07, 2026.
What were Veradigm earnings last quarter?
MDRX earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0.01 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Veradigm revenue for the last year?
Veradigm revenue for the last year amounts to 1.18B USD.
What is Veradigm net income for the last year?
MDRX net income for the last year is -172.92M USD.
Does Veradigm pay dividends?
Yes, MDRX dividends are paid en. The last dividend per share was 5.23 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Veradigm have?
As of June 16, 2026, the company has 2,450 employees.
In which sector is Veradigm located?
Veradigm operates in the Health & Wellness sector.
When did Veradigm complete a stock split?
Veradigm has not had any recent stock splits.
Where is Veradigm headquartered?
Veradigm is headquartered in Chicago, United States.